Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Gillis Steven

Over the trailing 90 days, Gillis Steven (Other at Kardigan, Inc.) traded $45.5M of stock (net buying $34.1M) across 4 companies, per 16 SEC Form 4 transactions.

Role
Other
Companies
KARD SPTX TAK BOLD
Window
Trailing 90 days · 16 transactions · CIK 1229592
Net activity
+$34.1M ($39.8M bought · $5.7M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
KARDKardigan, Inc.5$20.0M$20.0M
SPTXSeaport Therapeutics, Inc.5$19.8M$19.8M
TAKTAKEDA PHARMACEUTICAL CO LTD3$5.7M−$5.7M
BOLDBoundless Bio, Inc.3$16K$40K−$23K

Transactions (16)

DateSymbolTypeSharesValueDescription
2026-07-10TAKSell1.2K$5.7MDisposition to the issuer of issuer equity securities
2026-07-01TAKBuy3.8K$0Grant, award or other acquisition
2026-07-01TAKBuy1.3K$0Grant, award or other acquisition
2026-07-01BOLDSell16.0K$0Exercise or conversion of derivative security
2026-07-01BOLDSell16.0K$40KOpen market or private sale
2026-07-01BOLDBuy16.0K$16KExercise or conversion of derivative security
2026-06-22KARDBuy1.2M$20.0MOpen market or private purchase
2026-06-17KARDSell2.3M$0Conversion of derivative security
2026-06-17KARDSell1.2M$0Conversion of derivative security
2026-06-17KARDSell5.1M$0Conversion of derivative security
2026-06-17KARDBuy13.8M$0Conversion of derivative security
2026-05-04SPTXBuy1.1M$19.8MOpen market or private purchase
2026-05-04SPTXBuy2.5M$0Conversion of derivative security
2026-05-04SPTXBuy2.7M$0Conversion of derivative security
2026-05-04SPTXSell2.5M$0Conversion of derivative security
2026-05-04SPTXSell2.7M$0Conversion of derivative security

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Gillis's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free